A Florida-based company that has promoted its Isoprex supplement to older adults as a miracle cure for pain and joint inflammation has agreed to a settlement with the Federal Trade Commission that bars the company from continuing to make its unproven claims. The proposed court order settling the FTC’s complaint would prohibit Renaissance Health Publishing, […]
Tag Archives: Over-the-Counter Drugs and Devices Bureau of Consumer Protection Consumer Protection Advertising and Marketing
FTC Takes Action to Stop Anti-Aging “Cure-All” Marketers From Making Baseless Health Claims
The sellers of a pill called ReJuvenation settled Federal Trade Commission charges that they deceptively claimed that their product is a virtual cure-all for age-related ailments—including cell damage, heart attack damage, brain damage, blindness, and deafness—and even aging itself. The orders settling the FTC’s complaint prohibit the defendants from making such claims unless they are […]
Overseas Payment Processor and its Former CEO Settle FTC Allegations That They Enabled a Deceptive “Free Trial” Offer Scheme
A Latvian payment processor and its former CEO have agreed to settle the Federal Trade Commission’s complaint against them. The complaint alleges that they engaged in unlawful conduct that enabled a deceptive “free trial” offer scheme by U.S.-based defendants. “Transact Pro helped scammers drain people’s accounts without their permission,” said Andrew Smith, Director of the […]
FTC Stops Marketers from Making False Arthritis Treatment Claims
The marketers of a dietary supplement called Synovia agreed to settle Federal Trade Commission charges by halting the deceptive tactics they allegedly used to mislead consumers into thinking Synovia could treat arthritis and alleviate joint pain. The FTC’s proposed settlement with Colorado-based A.S. Research, LLC (ASR) and its two owners, Stephen J. Young and Michael […]
FTC Approves Final Order Settling Charges that Company’s Head Lice Protection Claims Were Deceptive
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that personal care company Lornamead, Inc. deceived consumers with exaggerated claims that its “Lice Shield” shampoo, stick, and spray products will prevent or reduce the risk of getting head lice. According to the FTC’s complaint, Lornamead claimed in print […]
Marketers of ‘Fat Burning’ and ‘Calorie Blocking’ Diet Pills to Pay $500,000 for Making Deceptive Weight Loss Claims
The Quebec-based marketers of a supposed weight-loss treatment have agreed to pay $500,000 to settle Federal Trade Commission charges that they deceived consumers with bogus claims that their Double Shot pills would cause rapid, substantial, and permanent weight loss, without diet or exercise. According to the FTC’s complaint, Manon Fernet and the company she controls, […]
FTC Takes Action Against Companies Marketing Allegedly Unproven Natural Bed Bug and Head Lice Treatments
The Federal Trade Commission filed deceptive advertising charges against two marketers of remedies for bed bug infestations, who allegedly failed to back up overhyped claims that they could prevent and eliminate infestations using natural ingredients, such as cinnamon and cedar oil. One marketer also allegedly made misleading claims that its products were effective against head […]